Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 British Society for Rheumatology


research-article

A PROSPECTIVE FIVE-YEAR COMPARISON OF TREATMENT WHICH INCLUDED PENICILLAMINE WITH THAT EXCLUDING PENICILLAMINE IN EARLY RHEUMATOID ARTHRITIS

THE MULTICENTRE TRIAL GROUP*

Correspondence to: Address correspondence to Dr. W. H. Lyle

Seventy-three patients with early, active rheumatoid arthritis (RA) were randomly allocated either to a group that received penicillamine or to a control group from which penicillamine was barred, any other second-line drug being permitted. Most (87%) of the controls received chrysotherapy at some stage. Clinical, serological and radiographic progress was observed for at least 5 years. Outcome after 5 years for the 27 remaining in the penicillamine group was compared with that for the 23 surviving controls. Both groups had improved clinically but deteriorated radiographically, with much individual variation. A subset of patients, mostly seronegative, who were radiographically normal at the outset remained so, regardless of treatment. Penicillamine was as effective as the control group treatments in relieving synovitis and as ineffective in arresting radiographic deterioration.

KEY WORDS: Penicillamine, Rheumatoid arthritis, Radiography

*E. G. L. Bywaters, Royal Postgraduate Medical School, London; A. V. Camp, Wycombe General Hospital; A. T. Day, J. R. Golding, Royal Bath Hospital, Harrogate; A. M. Freeman, D. N. Golding, Princess Alexandra Hospital, Harlow; C. L. Greenbury, A. G. S. Hill, H. F. H. Hill and M. Webley, Stoke Mandeville Hospital, Aylesbury; I. M. Koch, Dista Products; W. H. Lyle, 7 Astley Close, Leamington Spa, Warwickshire; K. MacRae, Charing Cross Hospital Medical School, London; A. J. Swannell, City Hospital, Nottingham.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.